Very good news! Shows that synDNA has other market potential in the area of vaccines for bacteria based infections.
"What is brucellosis?
It is a contagious, costly disease of ruminant animals that also affects humans. Although brucellosis can attack other animals, its main threat is to cattle, bison, and swine. The disease is also known as contagious abortion or Bang's disease. In humans, it's known as undulant fever because of the severe intermittent fever accompanying human infection or Malta fever because it was first recognized as a human disease on the island of Malta.--
Brucella abortus vaccine produces a bodily response that increases the animal's resistance to the disease. However, vaccination is not 100-percent effective in preventing brucellosis; it typically protects about 65 percent of the vaccinated cattle from becoming infected by an average exposure to Brucell"
I suspect that the attractive features here are that synDNA tests have already been shown to be very effective in animals as well as being a new low cost source of plasmic DNA vaccine.
And if the present vaccines only protect about 65% of the animals--that's a bit discouraging.
Gutaquest
News 
Market Data 
Discover 
AI
